4 news items
Paladin Labs Announces Approval of WAKIX® (pitolisant hydrochloride tablets) For Use in Pediatric Patients in Canada
ENDPQ
28 Mar 24
its plan of reorganization ; the timing, impact or results of any pending or future litigation, investigations, proceedings or claims
Endo Launches Ibuprofen-Famotidine Tablets, Generic Version of DUEXIS®
ENDPQ
26 Mar 24
pending or future litigation, investigations, proceedings or claims, including opioid, tax and antitrust related matters; any actual or contingent
Endo Announces Confirmation of Plan of Reorganization
ENDPQ
19 Mar 24
of factors, including, among other things, the following: the timing, impact or results of any pending or future litigation, investigations, proceedings
ENDO REPORTS FOURTH-QUARTER 2023 FINANCIAL RESULTS
ENDPQ
6 Mar 24
, investigations
- Prev
- 1
- Next